Who Paid My Doc
Baber Khatib
Oral & Maxillofacial Surgery Portland, OR Medical Doctor
NPI 1356662845 CMS profile 4220825
1849 Nw Kearney St Ste 300, Portland, OR 97209
General payments
$107,275
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Baber Khatib of Portland, OR is reported in the CMS Open Payments database as having received $107,275 across 184 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $31,339 | 32 | |
| 2024 | General | $10,493 | 18 | |
| 2023 | General | $25,614 | 61 | |
| 2022 | General | $15,544 | 22 | |
| 2021 | General | $21,777 | 28 | |
| 2020 | General | $1,362 | 6 | |
| 2019 | General | $1,147 | 17 |
Beside peers
- Baber Khatib
- Oral & Maxillofacial Surgery median
- Middle half of Oral & Maxillofacial Surgery
- National median
In program year 2025, general payments to Baber Khatib were reported at $31,339. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.
Show as a table
| Year | Baber Khatib | Oral & Maxillofacial Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,147 | $178 | $56–$584 | $163 |
| 2020 | $1,362 | $106 | $38–$316 | $114 |
| 2021 | $21,777 | $165 | $57–$511 | $132 |
| 2022 | $15,544 | $173 | $63–$494 | $149 |
| 2023 | $25,614 | $184 | $62–$521 | $160 |
| 2024 | $10,493 | $197 | $65–$603 | $164 |
| 2025 | $31,339 | $184 | $61–$541 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 6 drugsPart D claims
459
Drug cost
$2,827
Branded share of claims
42.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Chlorhexidine Gluconate | Generic | 161 | $1,161 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 138 | $684 | |
| Amoxicillin | Generic | 83 | $339 | |
| Ondansetron Odt Ondansetron | Brand | 39 | $312 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 18 | $178 | |
| Clindamycin Hcl | Generic | 20 | $153 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 692 Part D prescribers listed as Maxillofacial Surgery; they describe a distribution and say nothing about conduct.
Records
184 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Oral & Maxillofacial Surgery in Oregon
Richard Bell
Oral & Maxillofacial Surgery · Portland, OR
Ashish Patel
Oral & Maxillofacial Surgery · Portland, OR
Mark Engelstad
Oral & Maxillofacial Surgery · Portland, OR
Eric Dierks
Oral & Maxillofacial Surgery · Portland, OR
Daniel Petrisor
Oral & Maxillofacial Surgery · Portland, OR
Allen Cheng
Oral & Maxillofacial Surgery · Portland, OR
Related records
Oral & Maxillofacial Surgery in Oregon
Practitioners in the same specialty and state, ranked by reported value.
All Oral & Maxillofacial Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Oregon
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.